Skip to main content
SpringerLink
Log in
Book cover

Management of Atopic Dermatitis pp 139–159Cite as

Adherence in Atopic Dermatitis

  • Chapter
  • First Online:

Part of the book series: Advances in Experimental Medicine and Biology ((AEMB,volume 1027))

Abstract

Atopic dermatitis is a chronic dermatologic condition requiring extended treatment times with topical application of medications. While atopic dermatitis treatments can be highly effective when used as directed, oftentimes patients do not respond as expected, raising concern for non-adherence versus non-response. This chapter aims to describe what is currently known about adherence in atopic dermatitis and to discuss strategies to improve adherence in order to improve treatment outcomes. Whether intentional or unintentional, non-adherence to treatment can limit patient outcomes of this disease for a variety of reasons. These include frustration with medication efficacy, inconvenience, and fear of side effects. Other factors include forgetfulness, financial burden of treatment, lack of trust in the physician, dislike of prescribed medication, or lack of understanding of disease or treatment. Several interventions have been studied with the aim of improving adherence in atopic dermatitis—such as educational workshops for patients and caregivers, earlier follow-up visits, and text messages reminders—however these are often limited by sample size and power. Further research is needed to study both specific patterns of nonadherence in atopic dermatitis, as well as methods to improve them.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Bass AM, Anderson KL, Feldman SR. Interventions to increase treatment adherence in pediatric atopic dermatitis: a systematic review. J Clin Med. 2015;4(2):231–42. doi:10.3390/jcm4020231.

    Article  PubMed  PubMed Central  Google Scholar 

  2. Patel NU, D’Ambra V, Feldman SR. Increasing adherence with topical agents for atopic dermatitis. Am J Clin Dermatol. 2017;8(3):323–32. doi:10.1007/s40257-017-0261-5.

    Article  Google Scholar 

  3. Brown KK, Rehmus WE, Kimball AB. Determining the relative importance of patient motivations for nonadherence to topical corticosteroid therapy in psoriasis. J Am Acad Dermatol. 2006;55(4):607–13. doi:10.1016/j.jaad.2005.12.021.

    Article  PubMed  Google Scholar 

  4. Kelsay K, Klinnert M, Bender B. Addressing psychosocial aspects of atopic dermatitis. Immunol Allergy Clin N Am. 2010;30(3):385–96. doi:10.1016/j.iac.2010.05.003.

    Article  Google Scholar 

  5. Fawcett J. Compliance: definitions and key issues. J Clin Psychiatry. 1995;56(Suppl 1):4–8; discussion 9–10. http://www.ncbi.nlm.nih.gov/pubmed/7836349. Accessed 13 Sept 2016.

    PubMed  Google Scholar 

  6. Chakrabarti S. What’s in a name? Compliance, adherence and concordance in chronic psychiatric disorders. World J Psychiatry. 2014;4(2):30–6. doi:10.5498/wjp.v4.i2.30.

    Article  PubMed  PubMed Central  Google Scholar 

  7. Burkhart PV, Sabaté E. Adherence to long-term therapies: evidence for action. J Nurs Scholarsh. 2003;35(3):207. http://www.ncbi.nlm.nih.gov/pubmed/14562485. Accessed 18 Jan 2017.

    PubMed  Google Scholar 

  8. Julius RJ, Novitsky MA, Dubin WR. Medication adherence: a review of the literature and implications for clinical practice. J Psychiatr Pract. 2009;15(1):34–44. doi:10.1097/01.pra.0000344917.43780.77.

    Article  PubMed  Google Scholar 

  9. Velligan DI, Weiden PJ, Sajatovic M, et al. The expert consensus guideline series: adherence problems in patients with serious and persistent mental illness. J Clin Psychiatry. 2009;70(Suppl 4):1–46; quiz 47–8. http://www.ncbi.nlm.nih.gov/pubmed/19686636. Accessed 16 Mar 2017.

    PubMed  Google Scholar 

  10. Storm A, Andersen SE, Benfeldt E, Serup J. One in 3 prescriptions are never redeemed: primary nonadherence in an outpatient clinic. J Am Acad Dermatol. 2008;59(1):27–33. doi:10.1016/j.jaad.2008.03.045.

    Article  PubMed  Google Scholar 

  11. Brodtkorb E, Samsonsen C, Sund JK, Bråthen G, Helde G, Reimers A. Treatment non-adherence in pseudo-refractory epilepsy. Epilepsy Res. 2016;122:1–6. doi:10.1016/j.eplepsyres.2016.02.001.

    Article  PubMed  Google Scholar 

  12. Horne R, Weinman J, Barber N, Elliott R. Concordance, adherence and compliance in medicine taking. Report for the National Co-ordinating Centre for NHS Service Delivery and Organisation R & D (NCCSDO). 2005:1–331. doi:10.1007/SpringerReference_64584.

  13. Clifford S, Barber N, Horne R. Understanding different beliefs held by adherers, unintentional nonadherers, and intentional nonadherers: application of the necessity–concerns framework. J Psychosom Res. 2008;64(1):41–6. doi:10.1016/j.jpsychores.2007.05.004.

    Article  PubMed  Google Scholar 

  14. Gadkari AS, McHorney CA. Unintentional non-adherence to chronic prescription medications: how unintentional is it really? BMC Health Serv Res. 2012;12(1):98. doi:10.1186/1472-6963-12-98.

    Article  PubMed  PubMed Central  Google Scholar 

  15. Richards HL, Fortune DG, O’Sullivan TM, Main CJ, Griffiths CE. Patients with psoriasis and their compliance with medication. J Am Acad Dermatol. 1999;41(4):581–3. http://www.ncbi.nlm.nih.gov/pubmed/10495380. Accessed 16 Mar 2017.

    CAS  PubMed  Google Scholar 

  16. Krejci-Manwaring J, Tusa MG, Carroll C, et al. Stealth monitoring of adherence to topical medication: adherence is very poor in children with atopic dermatitis. J Am Acad Dermatol. 2007;56(2):211–6. doi:10.1016/j.jaad.2006.05.073.

    Article  PubMed  Google Scholar 

  17. Carroll CL, Feldman SR, Camacho FT, Manuel JC, Balkrishnan R. Adherence to topical therapy decreases during the course of an 8-week psoriasis clinical trial: commonly used methods of measuring adherence to topical therapy overestimate actual use. J Am Acad Dermatol. 2004;51(2):212–6. doi:10.1016/j.jaad.2004.01.052.

    Article  PubMed  Google Scholar 

  18. Hix E, Gustafson CJ, O’Neill JL, et al. Adherence to a five day treatment course of topical fluocinonide 0.1% cream in atopic dermatitis. Dermatol Online J. 2013;19(10):20029.

    PubMed  Google Scholar 

  19. Yentzer BA, Camacho FT, Young T, Fountain JM, Clark AR, Feldman SR. Good adherence and early efficacy using desonide hydrogel for atopic dermatitis: results from a program addressing patient compliance. J Drugs Dermatol. 2010;9(4):324–9. http://www.ncbi.nlm.nih.gov/pubmed/20514788. Accessed 20 Oct 2016.

    PubMed  Google Scholar 

  20. Furue M, Onozuka D, Takeuchi S, et al. Poor adherence to oral and topical medication in 3096 dermatological patients as assessed by the Morisky Medication Adherence Scale-8. Br J Dermatol. 2015;172(1):272–5. doi:10.1111/bjd.13377.

    Article  CAS  PubMed  Google Scholar 

  21. Pena-Robichaux V, Kvedar JC, Watson AJ. Text messages as a reminder aid and educational tool in adults and adolescents with atopic dermatitis: a pilot study. Dermatol Res Pract. 2010;2010 doi:10.1155/2010/894258.

  22. Ellis RM, Koch LH, McGuire E, Williams JV. Potential barriers to adherence in pediatric dermatology. Pediatr Dermatol. 2011;28(3):242–4. doi:10.1111/j.1525-1470.2011.01493.x.

    Article  PubMed  Google Scholar 

  23. Ohya Y, Williams H, Steptoe A, et al. Psychosocial factors and adherence to treatment advice in childhood atopic dermatitis. J Invest Dermatol. 2001;117(4):852–7. doi:10.1046/j.0022-202x.2001.01475.x.

    Article  CAS  PubMed  Google Scholar 

  24. Serup J, Lindblad AK, Maroti M, et al. To follow or not to follow dermatological treatment. Acta Derm Venereol. 2006;86(3):193–7. doi:10.2340/00015555-0073.

    Article  PubMed  Google Scholar 

  25. Ulff E, Maroti M, Kettis-Lindblad Å, et al. Single application of a fluorescent test cream by healthy volunteers: assessment of treated and neglected body sites. Br J Dermatol. 2007;156(5):974–8. doi:10.1111/j.1365-2133.2007.07754.x.

    Article  CAS  PubMed  Google Scholar 

  26. Charman C, Williams H. The use of corticosteroids and corticosteroid phobia in atopic dermatitis. Clin Dermatol. 2003;21(3):193–200. http://www.ncbi.nlm.nih.gov/pubmed/12781437. Accessed 20 Oct 2016.

    Article  PubMed  Google Scholar 

  27. Surber C, Itin PH, Bircher AJ, Maibach HI. Topical corticosteroids. J Am Acad Dermatol. 1995;32(6):1025–30. http://www.ncbi.nlm.nih.gov/pubmed/7751447. Accessed 20 Oct 2016.

    Article  CAS  PubMed  Google Scholar 

  28. Aubert-Wastiaux H, Moret L, Le Rhun A, et al. Topical corticosteroid phobia in atopic dermatitis: a study of its nature, origins and frequency. Br J Dermatol. 2011;165(4):808–14. doi:10.1111/j.1365-2133.2011.10449.x.

    Article  CAS  PubMed  Google Scholar 

  29. Hon K-LE, Kam W-YC, Leung T-F, et al. Steroid fears in children with eczema. Acta Paediatr. 2006;95(11):1451–5. doi:10.1080/08035250600612298.

    Article  PubMed  Google Scholar 

  30. El Hachem M, Gesualdo F, Ricci G, et al. Topical corticosteroid phobia in parents of pediatric patients with atopic dermatitis: a multicentre survey. Ital J Pediatr. 2017;43(1):22. doi:10.1186/s13052-017-0330-7.

    Article  PubMed  PubMed Central  Google Scholar 

  31. Charman CR, Morris AD, Williams HC. Topical corticosteroid phobia in patients with atopic eczema. Br J Dermatol. 2000;142(5):931–6. doi:10.1046/j.1365-2133.2000.03473.x.

    Article  CAS  PubMed  Google Scholar 

  32. Lee JY, Her Y, Kim CW, Kim SS. Topical corticosteroid phobia among parents of children with atopic eczema in Korea. Ann Dermatol. 2015;27(5):499–506. doi:10.5021/ad.2015.27.5.499.

    Article  PubMed  PubMed Central  Google Scholar 

  33. Beattie PE, Lewis-Jones MS. Parental knowledge of topical therapies in the treatment of childhood atopic dermatitis. Clin Exp Dermatol. 2003;28(5):549–53. doi:10.1046/j.1365-2230.2003.01357.x.

    Article  CAS  PubMed  Google Scholar 

  34. Sagransky MJ, Yentzer BA, Williams LL, Clark AR, Taylor SL, Feldman SRA. randomized controlled pilot study of the effects of an extra office visit on adherence and outcomes in atopic dermatitis. Arch Dermatol. 2010;146(12):1428–30. doi:10.1001/archdermatol.2010.368.

    Article  PubMed  Google Scholar 

  35. Halling-Overgaard A-S, Kezic S, Jakasa I, Engebretsen KA, Maibach H, Thyssen JP. Skin absorption through atopic dermatitis skin: a systematic review. Br J Dermatol. 2016; doi:10.1111/bjd.15065.

  36. Siegfried EC, Jaworski JC, Kaiser JD, Hebert AA. Systematic review of published trials: long-term safety of topical corticosteroids and topical calcineurin inhibitors in pediatric patients with atopic dermatitis. BMC Pediatr. 2016;16:75. doi:10.1186/s12887-016-0607-9.

    Article  PubMed  PubMed Central  Google Scholar 

  37. Oranje A, Devillers A, Kunz B, et al. Treatment of patients with atopic dermatitis using wet-wrap dressings with diluted steroids and/or emollients. An expert panel’s opinion and review of the literature. J Eur Acad Dermatol Venereol. 2006;20(10):1277–86. doi:10.1111/j.1468-3083.2006.01790.x.

    Article  CAS  PubMed  Google Scholar 

  38. Rork JF, Sheehan WJ, Gaffin JM, et al. Parental response to written eczema action plans in children with eczema. Arch Dermatol. 2012;148(3):391–2. doi:10.1001/archdermatol.2011.2267.

    Article  PubMed  PubMed Central  Google Scholar 

  39. Moore EJ, Williams A, Manias E, Varigos G, Donath S. Eczema workshops reduce severity of childhood atopic eczema. Australas J Dermatol. 2009;50(2):100–6. doi:10.1111/j.1440-0960.2009.00515.x.

    Article  PubMed  Google Scholar 

  40. Shaw M, Morrell DS, Goldsmith LA. A study of targeted enhanced patient care for pediatric atopic dermatitis (STEP PAD). Pediatr Dermatol. 2008;25(1):19–24. doi:10.1111/j.1525-1470.2007.00575.x.

    Article  PubMed  Google Scholar 

  41. Grillo M, Gassner L, Marshman G, Dunn S, Hudson P. Pediatric atopic eczema: the impact of an educational intervention. Pediatr Dermatol. 2006;23(5):428–36. doi:10.1111/j.1525-1470.2006.00277.x.

    Article  PubMed  Google Scholar 

  42. Staab D, von Rueden U, Kehrt R, et al. Evaluation of a parental training program for the management of childhood atopic dermatitis. Pediatr Allergy Immunol. 2002;13(2):84–90. http://www.ncbi.nlm.nih.gov/pubmed/12000479. Accessed 18 Oct 2016.

    Article  PubMed  Google Scholar 

  43. Chinn DJ, Poyner T, Sibley G. Randomized controlled trial of a single dermatology nurse consultation in primary care on the quality of life of children with atopic eczema. Br J Dermatol. 2002;146(3):432–9. http://www.ncbi.nlm.nih.gov/pubmed/11952543. Accessed 18 Oct 2016.

    Article  CAS  PubMed  Google Scholar 

  44. Patel NU, Moore BA, Craver RF, Feldman SR. Ethical considerations in adherence research. Patient Prefer Adherence. 2016;10:2429–35. doi:10.2147/PPA.S117802.

    Article  PubMed  PubMed Central  Google Scholar 

  45. Balato N, Megna M, Di Costanzo L, Balato A, Ayala F. Educational and motivational support service: a pilot study for mobile-phone-based interventions in patients with psoriasis. Br J Dermatol. 2013;168(1):201–5. doi:10.1111/j.1365-2133.2012.11205.x.

    Article  CAS  PubMed  Google Scholar 

  46. Long CC, Funnell CM, Collard R, Finlay AY. What do members of the National Eczema Society really want? Clin Exp Dermatol. 1993;18(6):516–22. doi:10.1111/j.1365-2230.1993.tb01020.x.

    Article  CAS  PubMed  Google Scholar 

  47. Santer M, Muller I, Yardley L, Lewis-Jones S, Ersser S, Little P. Parents’ and carers’ views about emollients for childhood eczema: qualitative interview study. BMJ Open. 2016;6(8):e011887. doi:10.1136/bmjopen-2016-011887.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  48. Cork MJ, Britton J, Butler L, Young S, Murphy R, Keohane SG. Comparison of parent knowledge, therapy utilization and severity of atopic eczema before and after explanation and demonstration of topical therapies by a specialist dermatology nurse. Br J Dermatol. 2003;149(3):582–9. doi:10.1046/j.1365-2133.2003.05595.x.

    Article  CAS  PubMed  Google Scholar 

  49. Ersser SJ, Cowdell F, Latter S, et al. Psychological and educational interventions for atopic eczema in children. Cochrane Database Syst Rev. 2014;1:CD004054. doi:10.1002/14651858.CD004054.pub3.

    Google Scholar 

  50. Broberg A, Kalimo K, Lindblad B, Swanbeck G. Parental education in the treatment of childhood atopic eczema. Acta Derm Venereol. 1990;70(6):495–9. http://www.ncbi.nlm.nih.gov/pubmed/1981422. Accessed 21 Oct 2016.

    CAS  PubMed  Google Scholar 

  51. Fenerty SD, O’Neill JL, Gustafson CJ, et al. Maternal adherence factors in the treatment of pediatric atopic dermatitis. JAMA Dermatol. 2013;149(2):229. doi:10.1001/2013.jamadermatol.253.

    Article  PubMed  Google Scholar 

  52. Feldman SR, Camacho FT, Krejci-Manwaring J, Carroll CL, Balkrishnan R. Adherence to topical therapy increases around the time of office visits. J Am Acad Dermatol. 2007;57(1):81–3. doi:10.1016/j.jaad.2007.04.005.

    Article  PubMed  Google Scholar 

  53. Feldman SR. The parable of the piano teacher. The Dermatologist. 2007;15(8). http://www.the-dermatologist.com/article/7570.

  54. Evangelista MTP, Abad-Casintahan F, Lopez-Villafuerte L. The effect of topical virgin coconut oil on SCORAD index, transepidermal water loss, and skin capacitance in mild to moderate pediatric atopic dermatitis: a randomized, double-blind, clinical trial. Int J Dermatol. 2014;53(1):100–8. doi:10.1111/ijd.12339.

    Article  PubMed  Google Scholar 

  55. Canpolat F, Erkoçoğlu M, Tezer H, Kocabaş CN, Kandi B. Hydrocortisone acetate alone or combined with mupirocin for atopic dermatitis in infants under two years of age—a randomized double blind pilot trial. Eur Rev Med Pharmacol Sci. 2012;16(14):1989–93. http://www.ncbi.nlm.nih.gov/pubmed/23242727. Accessed 25 Oct 2016.

    CAS  PubMed  Google Scholar 

  56. Glenn C, McMichael A, Feldman SR. Measuring patient satisfaction changes patient satisfaction. J Dermatolog Treat. 2012;23(2):81–2. doi:10.3109/09546634.2012.666883.

    Article  PubMed  Google Scholar 

  57. Feldman SR. Tachyphylaxis to topical corticosteroids: the more you use them, the less they work? Clin Dermatol. 2006;24:229–30.

    Article  PubMed  Google Scholar 

  58. Kojima R, Fujiwara T, Matsuda A, et al. Factors associated with steroid phobia in caregivers of children with atopic dermatitis. Pediatr Dermatol. 2013;30(1):29–35. doi:10.1111/j.1525-1470.2012.01808.x.

    Article  PubMed  Google Scholar 

  59. van Os-Medendorp H, Koffijberg H, Eland-de Kok PCM, et al. E-health in caring for patients with atopic dermatitis: a randomized controlled cost-effectiveness study of internet-guided monitoring and online self-management training. Br J Dermatol. 2012;166(5):1060–8. doi:10.1111/j.1365-2133.2012.10829.x.

    Article  PubMed  Google Scholar 

  60. Santer M, Burgess H, Yardley L, et al. Managing childhood eczema: qualitative study exploring carers’ experiences of barriers and facilitators to treatment adherence. J Adv Nurs. 2013;69(11):2493–501. doi:10.1111/jan.12133.

    PubMed  Google Scholar 

  61. Luersen K, Davis SA, Kaplan SG, Abel TD, Winchester WW, Feldman SR. Sticker charts: a method for improving adherence to treatment of chronic diseases in children. Pediatr Dermatol. 2012;29(4):403–8. doi:10.1111/j.1525-1470.2012.01741.x.

    Article  PubMed  Google Scholar 

  62. Carroll CL, Balkrishnan R, Feldman SR, Fleischer AB, Manuel JC. The burden of atopic dermatitis: impact on the patient, family, and society. Pediatr Dermatol. 2005;22(3):192–9. doi:10.1111/j.1525-1470.2005.22303.x.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Dermatology, Wake Forest University School of Medicine, Winston Salem, NC, USA

    Nupur Patel M.S. & Steven R. Feldman M.D., Ph.D.

Authors
  1. Nupur Patel M.S.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Steven R. Feldman M.D., Ph.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Nupur Patel M.S. .

Editor information

Editors and Affiliations

  1. Department of Dermatology, Wake Forest University School of Medicine, Winston Salem, North Carolina, USA

    Erica A. Fortson

  2. Department of Dermatology, Wake Forest University School of Medicine, Winston Salem, North Carolina, USA

    Steven R. Feldman

  3. Department of Dermatology, Wake Forest University School of Medicine, Winston Salem, North Carolina, USA

    Lindsay C. Strowd

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer International Publishing AG

About this chapter

Cite this chapter

Patel, N., Feldman, S.R. (2017). Adherence in Atopic Dermatitis. In: Fortson, E., Feldman, S., Strowd, L. (eds) Management of Atopic Dermatitis. Advances in Experimental Medicine and Biology, vol 1027. Springer, Cham. https://doi.org/10.1007/978-3-319-64804-0_12

Download citation

Publish with us

Policies and ethics

Search

Navigation